Keyword: lung cancer drugs
News
16.02.2016
- US drugmaker Eli Lilly has lost the latest round in an ongoing legal fight in the UK over patents relating to the administration of vitamins given alongside its blockbuster lung...
News
08.02.2016
- European regulators have approved a lung cancer drug from UK-Swedish drug maker AstraZeneca. Tagrisso was the first new drug to win accelerated approval by the European Medicines...
News
11.12.2015
- An Indian court has unexpectedly sided with Swiss drugmaker Roche in a long-running patent dispute with Indian generics giant Cipla. A two-judge panel for the Delhi High Court...
News
26.09.2013
- Infinity Pharmaceuticals said its cancer drug failed to improve overall survival in a mid-stage study on patients with non-small cell lung cancer who had a history of smoking. The...
News
20.08.2013
- Eli Lilly, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds and wins a closely watched patent battle...
